Cancer and Inflammation Program, National Cancer Institute-Frederick, Frederick, MD 21702, USA.
J Leukoc Biol. 2011 Jan;89(1):11-9. doi: 10.1189/jlb.0410221. Epub 2010 Jul 19.
LAB/NTAL/Lat2 is a transmembrane adaptor protein closely related to LAT. It is expressed in various myeloid and lymphoid cells, many of which also express LAT. Phosphorylation of LAB occurs following engagement of various ITAM- and non-ITAM-linked receptors and can play positive and negative roles following receptor engagement. LAT binds PLCγ directly, resulting in efficient Ca²+ flux and degranulation. However, LAB does not contain a PLCγ-binding motif and only binds PLCγ indirectly, possibly via Grb2, thereby resulting in suboptimal signaling. As LAT can signal more efficiently than LAB, competition between the 2 for space/substrates in the lipid rafts can attenuate signaling. This competition model requires coexpression of LAT; however, LAB is repressive, even in cells lacking substantial LAT expression such as macrophages and mature B cells. The reported interaction between LAB and the ubiquitin E3-ligase c-Cbl suggests 1 possible mechanism for LAT-independent inhibition by LAB, but such a model requires further investigation. Given the wide-reaching expression pattern of LAB, LAB has the ability to modulate signaling in virtually every type of leukocyte. Regardless of its ultimate mode of action, the potent regulatory capability of LAB proves this protein to be a complex adaptor that warrants continued, substantial scrutiny by biochemists and immunologists alike.
LAB/NTAL/Lat2 是一种与 LAT 密切相关的跨膜衔接蛋白。它在各种髓系和淋巴样细胞中表达,其中许多细胞也表达 LAT。各种 ITAM 和非 ITAM 连接的受体结合后,LAB 发生磷酸化,在受体结合后可以发挥正、负调控作用。LAT 直接与 PLCγ 结合,导致 Ca²+ 流和脱颗粒的有效发生。然而,LAB 不含 PLCγ 结合基序,只能通过 Grb2 间接与 PLCγ 结合,从而导致信号传递效率降低。由于 LAT 比 LAB 能更有效地传递信号,因此在脂筏中,两者为争夺空间/底物而相互竞争,从而减弱信号传递。这种竞争模型需要 LAT 的共表达;然而,LAB 具有抑制作用,即使在缺乏大量 LAT 表达的细胞(如巨噬细胞和成熟 B 细胞)中也是如此。LAB 与泛素 E3 连接酶 c-Cbl 之间的报道相互作用表明,LAB 通过非 LAT 依赖的方式抑制信号转导的 1 种可能机制,但这种模型需要进一步研究。鉴于 LAB 广泛的表达模式,LAB 具有调节几乎所有类型白细胞信号转导的能力。无论其最终作用模式如何,LAB 的强大调节能力证明它是一种复杂的衔接蛋白,值得生物化学家和免疫学家继续深入研究。